G1 Therapeutics Net Profit Margin 2016-2024 | GTHX
G1 Therapeutics net profit margin from 2016 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Net Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Net Income |
Net Margin |
2024-06-30 |
$0.06B |
$-0.04B |
-75.86% |
2024-03-31 |
$0.08B |
$-0.03B |
-36.14% |
2023-12-31 |
$0.08B |
$-0.05B |
-58.54% |
2023-09-30 |
$0.08B |
$-0.07B |
-92.21% |
2023-06-30 |
$0.09B |
$-0.08B |
-87.64% |
2023-03-31 |
$0.06B |
$-0.13B |
-217.24% |
2022-12-31 |
$0.05B |
$-0.15B |
-282.69% |
2022-09-30 |
$0.05B |
$-0.15B |
-318.75% |
2022-06-30 |
$0.03B |
$-0.17B |
-586.21% |
2022-03-31 |
$0.03B |
$-0.17B |
-680.00% |
2021-12-31 |
$0.03B |
$-0.15B |
-459.38% |
2021-09-30 |
$0.04B |
$-0.13B |
-306.98% |
2021-06-30 |
$0.07B |
$-0.10B |
-156.92% |
2021-03-31 |
$0.06B |
$-0.09B |
-156.67% |